NVRO stock forecast
Our latest prediction for Nevro Corp.'s stock price was made on the Nov. 25, 2019 when the stock price was at 112.25$.
In the short term (2weeks), NVRO's stock price should underperform the market by -3.84%. During that period the price should oscillate between -8.27% and +6.02%.
In the medium term (3months), NVRO's stock price should underperform the market by -10.93%. During that period the price should oscillate between -26.61% and +13.35%.Get email alerts
Create a solid portfolio with NVRO
About Nevro Corp.
Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
At the moment the company generates 384M USD in revenues.
On its last earning announcement, the company reported a loss of -3.25$ per share.
The book value per share is 8.15$
Three months stock forecastNov. 25, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|